RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VERV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Verve Therapeutics, Inc. stock after gaining 0.682%
(Updated on Mar 28, 2024)

Sell candidate since Mar 25, 2024 Gain 0.91% PDF

The Verve Therapeutics, Inc. stock price gained 0.682% on the last trading day (Thursday, 28th Mar 2024), rising from $13.19 to $13.28. During the last trading day the stock fluctuated 5.17% from a day low at $12.96 to a day high of $13.63. The price has been going up and down for this period, and there has been a -2.35% loss for the last 2 weeks. Volume fell on the last day by -3 thousand shares and in total, 630 thousand shares were bought and sold for approximately $8.37 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.56% during the next 3 months and, with a 90% probability hold a price between $13.14 and $20.53 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VERV Signals & Forecast

There are mixed signals in the stock today. The Verve Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.99. On a fall, the stock will find some support from the short-term average at $13.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 3.83%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Verve Therapeutics, Inc. stock

Verve Therapeutics, Inc. finds support from accumulated volume at $13.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.670 between high and low, or 5.17%. For the last week, the stock has had daily average volatility of 4.30%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VERV) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Verve Therapeutics, Inc. to open at $13.29, and during the day (based on 14 day Average True Range), to move between $12.40 and $14.16, which gives a possible trading interval of +/-$0.88 (+/-6.66%) up or down from last closing price. If Verve Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.32 (0.30%) than the support at $13.01 (2.03%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Verve Therapeutics, Inc. stock A Buy?

Verve Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.930 Sell Candidate Unchanged

Predicted Opening Price for Verve Therapeutics, Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$13.29 ( 0.0753%) $13.28

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VERV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.96 5.12 %
R2 13.70 3.19 %
R1 13.55 2.00 %
Current price: 13.28
Support S1 13.03 -1.85 %
S2 12.88 -3.04 %
S3 12.62 -4.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.92 4.82 %
R2 13.81 3.99 %
R1 13.32 0.301 %
Current price 13.28
Support S1 13.01 -2.03%
S2 13.00 -2.11%
S3 11.46 -13.70%

FAQ

What is the symbol for Verve Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Verve Therapeutics, Inc. is VERV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Verve Therapeutics, Inc. Stock?
Verve Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Verve Therapeutics, Inc. Stock?
Verve Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Verve Therapeutics, Inc. Stock.

What's the current price of Verve Therapeutics, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Verve Therapeutics, Inc. (VERV) share was $13.28.

What is the 52-week high and low for Verve Therapeutics, Inc. Stock?
The 52-week high for Verve Therapeutics, Inc. Stock is $21.42 and the 52-week low is $8.22.

What is the market capitalization of Verve Therapeutics, Inc. Stock?
As of the 2024-03-28, the market capitalization of Verve Therapeutics, Inc. is 1.043B.

When is the next earnings date for Verve Therapeutics, Inc.?
The upcoming earnings date for Verve Therapeutics, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT